Bayer CEO: Stefan Oelrich - mRNA Vaccine is Gene Therapy - 2023-05-27
Summary:
Stefan Oelrich, the CEO of Bayer, discusses the business opportunity for the company in the field of gene therapy. He mentions that the COVID-19 pandemic has allowed gene therapy to become more widely accepted, overcoming previous high refusal rates. Oelrich believes that gene therapy, including mRNA vaccines, has the potential to make a significant impact and bring about positive change. He mentions that if a survey had been conducted two years ago, the majority of people would have refused gene or cell therapy. However, the pandemic has opened people's eyes to the possibilities of innovation in healthcare.
Bayer CEO: Stefan Oelrich
00:00:00.119 --> 00:00:03.910
We're really taking that leap us as a company bayer
00:00:04.699 --> 00:00:07.880
in cell and gene therapy, which to me is one of these examples.
00:00:07.889 --> 00:00:12.359
We really, we're going to make a difference, hopefully moving forward.
00:00:12.369 --> 00:00:14.699
There are some uh ultimately, the,
00:00:14.710 --> 00:00:18.600
the M R N A vaccines are an example for that cell and gene therapy.
00:00:18.610 --> 00:00:21.600
I always like to say, if we had surveyed two years ago
00:00:22.000 --> 00:00:24.299
in the public, would you be willing to take
00:00:24.629 --> 00:00:25.440
gene
00:00:25.569 --> 00:00:28.750
gene or cell therapy and injected into your body?
00:00:28.770 --> 00:00:31.690
We would have probably had a 95% refusal rate.
00:00:31.700 --> 00:00:35.700
I think this pandemic has also opened many people's eyes to
00:00:35.840 --> 00:00:38.840
innovation in the way that was maybe not
00:00:38.970 --> 00:00:40.319
possible before.